发展药学研究,同时推进马拉维的药学教育和实践
Hanna Stambuli-Kumwenda1, Nelson Nyoloka2, Hope Michael Chadwala3
1University of North Carolina Project, Tidziwe Centre Private Bag A-104 Lilongwe, Malawi.
The International journal of pharmacy practice
|February 17, 2026
概括
马拉维目前的药房教育和实践正在进步,药剂师积极参与研究. 预计未来的教育进步将加强临床实践,并扩大对实施科学,人口健康和健康结果的研究.
科学领域:
- 药房教育和实践 药房教育和实践
- 药学研究 药学研究
- 马拉维的健康科学 在马拉维的健康科学
背景情况:
- 马拉维目前药学教育和实践格局的概述.
- 鉴定药剂师开展的现有研究活动.
研究的目的:
- 描述马拉维目前的药房教育,实践和研究.
- 评论正在进行的进展及其影响.
主要方法:
- 文献综述和马拉维药房当前数据的综合.
- 分析研究努力和教育进步.
主要成果:
- 马拉维的药剂师参与各种研究,包括抗菌药物管理,临床试验和药物使用过程.
- 药学教育的进步有望改善临床实践和药物护理.
- 预计将扩大实施科学,人口健康和健康结果的研究机会.
结论:
- 马拉维药房教育的进步将推动临床实践和药物护理的进步.
- 未来的研究很可能会集中在实施科学,人口健康和健康结果上,进一步加强专业.
相关概念视频
Pharmacovigilance
1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
Therapeutic Drug Monitoring: Affecting Factors
258
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
258
Pharmaceutical Poisoning: Potential Scenarios
19
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
19
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
22
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
22
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
229
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
229
Drug Administration and Therapy Phases: Overview
1.5K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.5K


